Live feed16:00:00·7mPRReleasevia QuantisnowInhibrx To Host Webcast Presentation to Provide Primary Endpoint Results for INBRX-106 Phase 2 First-Line HNSCC StudyByQuantisnow·Wall Street's wire, on your screen.INBX· Inhibrx Biosciences Inc.Health Care
